Los Angeles Times

Melody Petersen

Writer

Melody Petersen covers biotechnology for the Los Angeles Times. Previously, she wrote about the pharmaceutical industry for the New York Times. She won a Loeb award for reporting about a power company at the San Jose Mercury News. She has also written for the Orange County Register and the Philadelphia Inquirer. She’s the author of Our Daily Meds, a book about the drug industry. She’s a former certified public accountant and grew up on an Iowa farm.

Recent Articles

  • Mylan CEO blames rising cost of the EpiPen on 'opaque' industry pricing

    Mylan CEO blames rising cost of the EpiPen on 'opaque' industry pricing

    Lawmakers blasted the chief executive of the maker of EpiPens at a House hearing Wednesday, saying the company’s price hikes of more than 500% were stopping families from keeping their children safe. “Do you have a guilty conscience about any of this?” Rep. Scott DesJarlais (R-Tenn.) asked Mylan...

  • Is Elon Musk trying to do too much too fast?

    Is Elon Musk trying to do too much too fast?

    If you deal in cars and rockets, you’re going to have crashes and blasts. But how many crashes and blasts before your business takes a fatal hit? That’s one of many questions facing Elon Musk, now engaged in one of the most fascinating stories in the history of business, a story playing out in...

65°